Edges in Network
| Network | GSE18864_egf1520 - GSE18864 - SiGN-BN HC+Bootstrap |
| Network Description | Tumor expression data from neoadjuvant trial of cisplatin monotherapy in triple negative breast cancer patients |
| Node | ACTA2 |
| Upstream (Parents) |
|---|
| (<<) ATP11C → ACTA2 |
| (<<) CAV1 → ACTA2 |
| (<<) CYR61 → ACTA2 |
| (<<) IGFBP7 → ACTA2 |
| (<<) JAG1 → ACTA2 |
| (<<) MYLK → ACTA2 |
| (<<) PPAP2A → ACTA2 |
| (<<) RNF138 → ACTA2 |
| (<<) RRP15 → ACTA2 |
| (<<) TIMP2 → ACTA2 |
| Downstream (Children) |
|---|
| ACTA2 → ACTC1 (>>) |
| ACTA2 → AKT3 (>>) |
| ACTA2 → ANTXR1 (>>) |
| ACTA2 → CCDC3 (>>) |
| ACTA2 → CDH11 (>>) |
| ACTA2 → CDH3 (>>) |
| ACTA2 → CRK (>>) |
| ACTA2 → CTGF (>>) |
| ACTA2 → CYB5R3 (>>) |
| ACTA2 → DAB2 (>>) |
| ACTA2 → DEPDC7 (>>) |
| ACTA2 → DNM3 (>>) |
| ACTA2 → EFEMP2 (>>) |
| ACTA2 → ERP27 (>>) |
| ACTA2 → FAS (>>) |
| ACTA2 → FBXO32 (>>) |
| ACTA2 → FZD1 (>>) |
| ACTA2 → HK1 (>>) |
| ACTA2 → HSPA14 (>>) |
| ACTA2 → IL1F9 (>>) |
| ACTA2 → INHBA (>>) |
| ACTA2 → ISLR (>>) |
| ACTA2 → ITGB5 (>>) |
| ACTA2 → KLF7 (>>) |
| ACTA2 → MMP15 (>>) |
| ACTA2 → MMP2 (>>) |
| ACTA2 → MMP3 (>>) |
| ACTA2 → MMP7 (>>) |
| ACTA2 → MXRA8 (>>) |
| ACTA2 → MYL9 (>>) |
| ACTA2 → NMU (>>) |
| ACTA2 → NNMT (>>) |
| ACTA2 → NRG1 (>>) |
| ACTA2 → PELO (>>) |
| ACTA2 → PHLDA1 (>>) |
| ACTA2 → PIM1 (>>) |
| ACTA2 → PKIG (>>) |
| ACTA2 → PLAT (>>) |
| ACTA2 → PLAU (>>) |
| ACTA2 → PTRF (>>) |
| ACTA2 → RGS20 (>>) |
| ACTA2 → RPS6KA2 (>>) |
| ACTA2 → SLC6A14 (>>) |
| ACTA2 → ST3GAL6 (>>) |
| ACTA2 → SULF2 (>>) |
| ACTA2 → THY1 (>>) |
| ACTA2 → TIMP3 (>>) |
| ACTA2 → TPM2 (>>) |
| ACTA2 → TPP1 (>>) |
